These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 2104281

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human immune response to multiple injections of murine monoclonal IgG.
    Shawler DL, Bartholomew RM, Smith LM, Dillman RO.
    J Immunol; 1985 Aug; 135(2):1530-5. PubMed ID: 3874237
    [Abstract] [Full Text] [Related]

  • 4. The idiotypic characterization of the immune response to a defined epitope of a protein antigen and the specific in vivo suppression of the immune response to this epitope by anti-idiotypic antibodies.
    Norton FL, Morrow PR, Leung CY, Benjamini E.
    J Immunol; 1985 May; 134(5):3226-32. PubMed ID: 2580019
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3.
    Chatenoud L, Baudrihaye MF, Chkoff N, Kreis H, Goldstein G, Bach JF.
    J Immunol; 1986 Aug 01; 137(3):830-8. PubMed ID: 3487589
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Antibodies as antigens--idiotypes and idiotypic networks].
    Berchtold P.
    Schweiz Med Wochenschr; 1989 Nov 11; 119(45):1577-82. PubMed ID: 2479088
    [Abstract] [Full Text] [Related]

  • 11. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
    Foon KA, Oseroff AR, Vaickus L, Greenberg SJ, Russell D, Bernstein Z, Pincus S, Köhler H, Seon BK, Tahaoglu E.
    Clin Cancer Res; 1995 Nov 11; 1(11):1285-94. PubMed ID: 9815923
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A suppressive mechanism counteracts the production of anti-idiotype antibody.
    Korec E, Korcová J, Hlozánek I.
    Folia Biol (Praha); 1989 Nov 11; 35(5):347-50. PubMed ID: 2699293
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
    Schwegler C, Dorn-Beineke A, Nittka S, Stocking C, Neumaier M.
    Cancer Res; 2005 Mar 01; 65(5):1925-33. PubMed ID: 15753392
    [Abstract] [Full Text] [Related]

  • 19. Human monoclonal anti-idiotypic antibodies. I. Establishment of immortalized cell lines from a tumor patient treated with mouse monoclonal antibodies.
    Steinitz M, Tamir S, Frödin JE, Lefvert AK, Mellstedt H.
    J Immunol; 1988 Nov 15; 141(10):3516-22. PubMed ID: 2846688
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.